Milan, Italy

Gregor Leifker

This inventor holds 2 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Bayer Healthcare Aktiengesellschaft. Active years: 2004-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregor Leifker. Retrieved from https://idiyas.com/inventor/gregor-leifker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Gregor Leifker

Introduction

Gregor Leifker, a talented inventor based in Milan, Italy, has made notable contributions to the field of pharmaceutical innovations. He holds two patents that showcase his expertise and commitment to enhancing medical solutions.

Latest Patents

Gregor's latest patents focus on the development of stable salts of O-acetylsalicylic acid with basic amino acids. These innovative compounds present a significant advancement in the preparation of medicaments, providing new avenues for treatment.

Career Highlights

Throughout his career, Gregor has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. His tenure at these organizations has allowed him to develop and refine his inventive skills within a collaborative and research-focused environment.

Collaborations

Gregor has had the opportunity to collaborate with notable peers in the industry, including Gerhard Franckowiak and Hubert Appolt. These partnerships have further enriched his innovative journey, enabling him to share knowledge and foster creative problem-solving.

Conclusion

Gregor Leifker's contributions to innovation in the pharmaceutical sector exemplify the impact that determined inventors can have on healthcare solutions. With his dedication to invention and collaboration, he continues to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…